Skip to main content

Animations

MJFF Publications

2771 - 2780 of 6310 Results
Title
Year
  • Year
  • 2022
  • 2024
  • 2024
  • 2024
  • 2024
  • 2016
  • 2022
  • 2022
  • 2019
  • 2024
  • Summary Details
    OPEN
    Title: Subcellular proteomics of dopamine neurons in the mouse brain
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.7554/elife.70921
    Citation Count: 52
  • Summary Details
    OPEN
    Title: Direct and indirect regulation of β-glucocerebrosidase by the transcription factors USF2 and ONECUT2
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1038/s41531-024-00819-7
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Medication recommendation for Parkinson’s disease based on dynamics of symptom progression
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1038/s41598-024-76941-6
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Oral and gut microbiome profiles in people with early idiopathic Parkinson’s disease
    Journal Name: Communications Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1038/s43856-024-00630-8
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Sustained effect of prasinezumab on Parkinson’s disease motor progression in the open-label extension of the PASADENA trial
    Journal Name: Nature Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41591-024-03270-6
    Citation Count: 18
  • Summary Details
    OPEN
    Title: White matter microstructural characteristics in newly diagnosed Parkinson’s disease: An unbiased whole-brain study
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/srep35601
    Citation Count: 44
  • Summary Details
    OPEN
    Title: PKC isoforms activate LRRK1 kinase by phosphorylating conserved residues (Ser1064, Ser1074 and Thr1075) within the CORB GTPase domain
    Journal Name: Biochemical Journal
    Publisher: Portland Press Ltd.
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1042/bcj20220308
    Citation Count: 10
  • Summary Details
    OPEN
    Title: In situ architecture of the lipid transport protein VPS13C at ER–lysosome membrane contacts
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by, cc-by
    DOI - Digital Object Identifier: 10.1073/pnas.2203769119
    Citation Count: 62
  • Summary Details
    OPEN
    Title: Deep brain stimulation induced normalization of the human functional connectome in Parkinson’s disease
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/awz239
    Citation Count: 144
  • Summary Details
    OPEN
    Title: Dopamine Pathway and Parkinson's Risk Variants Are Associated with Levodopa‐Induced Dyskinesia
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.29960
    Citation Count: 3
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.